Clinical Trials Browser

Neuroendocrine Tumors × pasireotide × Gastrointestinal × Clear all

NCT01469572 2018-10-18

Pasireotide, Everolimus and Selective Internal Radioembolization Therapy for Unresectable Hepatic Metastases

Phase 1 Completed

EndocrineGastrointestinalNET

Liver Neoplasms, Neuroendocrine Tumors